4.5 Article

Biallelic variants in the synaptic vesicle glycoprotein 2 A are associated with epileptic encephalopathy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Broadening the phenotypic spectrum of the presumably epilepsy-related SV2A gene variants

Magdalena Badura-Stronka et al.

Summary: This article reports on a family affected by epilepsy, where a variant in the SV2A gene was identified. The findings further support the role of the SV2A gene in autosomal dominant epilepsy.

EPILEPSY RESEARCH (2023)

Review Neurosciences

Synaptic Vesicle Glycoprotein 2A: Features and Functions

Rachele Rossi et al.

Summary: SV2A, a transmembrane protein of synaptic vesicles, serves as a potential marker of synaptic density with stronger associations to GABAergic synapses. Despite being ubiquitously expressed, the biological function and interaction between SV2A and its tracers remain unclear. Further research is required for a better understanding of the protein's involvement in neurotransmission and its implications in neuroimaging studies.

FRONTIERS IN NEUROSCIENCE (2022)

Article Clinical Neurology

A de novo heterozygous rare variant in SV2A causes epilepsy and levetiracetam-induced drug-resistant status epilepticus

Daniel G. Calame et al.

Summary: Mutations in the SV2A gene can cause epilepsy, and there may be differences in response to LEV.

EPILEPSY & BEHAVIOR REPORTS (2021)

Article Clinical Neurology

Levetiracetam-induced a new seizure type in a girl with a novel SV2A gene mutation

Di Wang et al.

CLINICAL NEUROLOGY AND NEUROSURGERY (2019)

Article Cell Biology

SV2 regulates neurotransmitter release via multiple mechanisms

Amy Nowack et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)

Article Multidisciplinary Sciences

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

BA Lynch et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)